Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

keywords

  • Life Sciences & Biomedicine
  • MALIGNANT GLIOMA
  • MGMT
  • THERAPY

WoS ID

  • 000330533200010

end page

  • +

volume

  • 31